NCT04854382

Tailored Information About the Coronavirus for Patients With Chronic Kidney Disease

• Status: Unknown
• Phase: N/A
• Study type: Interventional
• Enrollment: 215 (estimated)
• Sponsor: Ivar Anders Eide · Academic / Other
• Sex: All
• Age: 18 Years
• Healthy volunteers: Not accepted

Summary

Randomized clinical trial focusing on the effect of tailored information on Covid-19 for patients with chronic kidney disease stage 5 on health literacy, anxiety and self-perceived health.

Detailed description

This single-center randomized open clinical trial in persons with chronic kidney disease stage 5 investigates the effect of information about coronavirus targeted at the study population, using study specific information videos followed by a teach-back method. We measure digital, functional, interactive and critical health literacy, fear of coronavirus and self-perceived health at baseline and end-of-study. Patients are followed from May-July 2021 through February 2022 (study period 7-9 months).

Conditions

• Renal Insufficiency, Chronic

Interventions

Type	Name	Description
BEHAVIORAL	Tailored information	Tailored information about coronavirus for patients with chronic kidney disease by information videos followed by a teach back procedure

Timeline

• Start date: 2021-04-14
• Primary completion: 2022-03-10
• Completion: 2023-12-31
• First posted: 2021-04-22
• Last updated: 2022-03-29

Locations

1 site across 1 country: Norway